Please login to the form below

Not currently logged in
Email:
Password:

Paul Navarre moves from Allergan to Ferring Pharmaceuticals

Takes up CEO role at its Ferring Holding subsidiary

Paul NavarreFerring Pharmaceuticals has appointed Paul Navarre as CEO of Ferring Holding Inc - a subsidiary of Ferring Pharmaceuticals, a privately owned, international pharma company - in a role that will see him assume responsibility for all of the group’s activities including commercial operations, clinical development and manufacturing.

Navarre has more than 25 years’ experience in the pharmaceuticals and consumer good industries and joins from Allergan, where he was president of Allergan International and managed a $3bn speciality care business covering dermatology, ophthalmology, urology and neurosciences.

Before joining Allergan, Navarre spent 15 years at Procter & Gamble holding positions in France, USA, Switzerland, Italy and the UK.

He said: “Ferring is a fast growing pharmaceutical company with a unique culture centred on people and patients.

“I am very excited to lead this organisation into the next phase of its development.”

As CEO, Navarre will report to the board of directors chaired by Michel Pettigrew, president of the executive board and chief operating officer of Ferring Group.

Pettigrew said: “Paul’s extensive pharmaceutical speciality care experience and proven international leadership skills will help him take our successful US operations to the next level, pursuing our rapid extension.”

Navarre succeeds Aaron Graff who has been appointed to a global role as executive vice president, chief commercial officer and member of the Ferring Group executive board.

6th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics